Changchun High-Tech Industry (000661.SZ): Application for clinical trial of GenSci143 for injection accepted.
Changchun High-tech (000661.SZ) announcement, the company's subsidiary - Changchun Jinsai Pharmaceutical Co., Ltd. ("Jinsai...
Changchun High-Tech Industry (000661.SZ) announced that its subsidiary, Changchun GenSci Pharmaceutical Co., Ltd. ("GenSci Pharmaceutical"), has received a written notification from the Food and Drug Administration of the United States (FDA) that its clinical trial application for injection of GenSci143 has been accepted, with indications for late-stage solid tumors.
Related Articles
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
RECOMMEND
